Literature DB >> 21193708

Parametric imaging using subharmonic signals from ultrasound contrast agents in patients with breast lesions.

John R Eisenbrey1, Jaydev K Dave, Daniel A Merton, Juan P Palazzo, Anne L Hall, Flemming Forsberg.   

Abstract

Parametric maps showing perfusion of contrast media can be useful tools for characterizing lesions in breast tissue. In this study we show the feasibility of parametric subharmonic imaging (SHI), which allows imaging of a vascular marker (the ultrasound contrast agent) while providing near complete tissue suppression. Digital SHI clips of 16 breast lesions from 14 women were acquired. Patients were scanned using a modified LOGIQ 9 scanner (GE Healthcare, Waukesha, WI) transmitting/receiving at 4.4/2.2 MHz. Using motion-compensated cumulative maximum intensity (CMI) sequences, parametric maps were generated for each lesion showing the time to peak (TTP), estimated perfusion (EP), and area under the time-intensity curve (AUC). Findings were grouped and compared according to biopsy results as benign lesions (n = 12, including 5 fibroadenomas and 3 cysts) and carcinomas (n = 4). For each lesion CMI, TTP, EP, and AUC parametric images were generated. No significant variations were detected with CMI (P = .80), TTP (P = .35), or AUC (P = .65). A statistically significant variation was detected for the average pixel EP (P = .002). Especially, differences were seen between carcinoma and benign lesions (mean ± SD, 0.10 ± 0.03 versus 0.05 ± 0.02 intensity units [IU]/s; P = .0014) and between carcinoma and fibroadenoma (0.10 ± 0.03 versus 0.04 ± 0.01 IU/s; P = .0044), whereas differences between carcinomas and cysts were found to be nonsignificant. In conclusion, a parametric imaging method for characterization of breast lesions using the high contrast to tissue signal provided by SHI has been developed. While the preliminary sample size was limited, results show potential for breast lesion characterization based on perfusion flow parameters.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21193708      PMCID: PMC6053048          DOI: 10.7863/jum.2011.30.1.85

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  20 in total

1.  Subharmonic imaging with microbubble contrast agents: initial results.

Authors:  W T Shi; F Forsberg; A L Hall; R Y Chiao; J B Liu; S Miller; K E Thomenius; M A Wheatley; B B Goldberg
Journal:  Ultrason Imaging       Date:  1999-04       Impact factor: 1.578

Review 2.  Ultrasound contrast imaging: current and new potential methods.

Authors:  P J Frinking; A Bouakaz; J Kirkhorn; F J Ten Cate; N de Jong
Journal:  Ultrasound Med Biol       Date:  2000-07       Impact factor: 2.998

3.  Diagnosis of breast cancer: contribution of US as an adjunct to mammography.

Authors:  H M Zonderland; E G Coerkamp; J Hermans; M J van de Vijver; A E van Voorthuisen
Journal:  Radiology       Date:  1999-11       Impact factor: 11.105

4.  In vivo perfusion estimation using subharmonic contrast microbubble signals.

Authors:  Flemming Forsberg; Ji-Bin Liu; William T Shi; Raymond Ro; Kathryn J Lipcan; Xuedong Deng; Anne L Hall
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

5.  On the ability of ultrasound parametric perfusion imaging to predict the area of infarction in acute ischemic stroke.

Authors:  G Seidel; H Cangür; K Meyer-Wiethe; G Renault; A Herment; A Schindler; C Kier
Journal:  Ultraschall Med       Date:  2006-12-05       Impact factor: 6.548

Review 6.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

7.  Contrast-assisted destruction-replenishment ultrasound for the assessment of tumor microvasculature in a rat model.

Authors:  Rachel E Pollard; Amy R Sadlowski; Susannah H Bloch; Lesley Murray; Erik R Wisner; Stephen Griffey; Katherine W Ferrara
Journal:  Technol Cancer Res Treat       Date:  2002-12

8.  Static and dynamic cumulative maximum intensity display mode for subharmonic breast imaging: a comparative study with mammographic and conventional ultrasound techniques.

Authors:  Jaydev K Dave; Flemming Forsberg; Savitha Fernandes; Catherine W Piccoli; Traci B Fox; Daniel A Merton; Lauren M Leodore; Anne L Hall
Journal:  J Ultrasound Med       Date:  2010-08       Impact factor: 2.153

9.  Parametric perfusion imaging with contrast-enhanced ultrasound in acute ischemic stroke.

Authors:  Martin Wiesmann; Karsten Meyer; Thomas Albers; Günter Seidel
Journal:  Stroke       Date:  2004-01-22       Impact factor: 7.914

Review 10.  Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts.

Authors:  J M Correas; L Bridal; A Lesavre; A Méjean; M Claudon; O Hélénon
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

View more
  16 in total

1.  Characterization of Adnexal Masses Using Contrast-Enhanced Subharmonic Imaging: A Pilot Study.

Authors:  Lauren J Delaney; Priscilla Machado; Mehnoosh Torkzaban; Andrej Lyshchik; Corinne E Wessner; Christine Kim; Norman Rosenblum; Scott Richard; Kirk Wallace; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2019-11-26       Impact factor: 2.153

2.  Quantitative analysis of vascular heterogeneity in breast lesions using contrast-enhanced 3-D harmonic and subharmonic ultrasound imaging.

Authors:  Anush Sridharan; John R Eisenbrey; Priscilla Machado; Haydee Ojeda-Fournier; Annina Wilkes; Alexander Sevrukov; Robert F Mattrey; Kirk Wallace; Carl L Chalek; Kai E Thomenius; Flemming Forsberg
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2015-03       Impact factor: 2.725

3.  Correlation of ultrasound contrast agent derived blood flow parameters with immunohistochemical angiogenesis markers in murine xenograft tumor models.

Authors:  John R Eisenbrey; Christian C Wilson; Raymond J Ro; Traci B Fox; Ji-Bin Liu; See-Ying Chiou; Flemming Forsberg
Journal:  Ultrasonics       Date:  2013-04-12       Impact factor: 2.890

4.  Volumetric contrast-enhanced ultrasound imaging of renal perfusion.

Authors:  Marshall Mahoney; Anna Sorace; Jason Warram; Sharon Samuel; Kenneth Hoyt
Journal:  J Ultrasound Med       Date:  2014-08       Impact factor: 2.153

5.  Parametric mapping of contrasted ovarian transvaginal sonography.

Authors:  Katrina Korhonen; Ryan Moore; Andrej Lyshchik; Arthur C Fleischer
Journal:  Ultrasound Q       Date:  2015-06       Impact factor: 1.657

6.  Interpretation of cardiac wall motion from cine-MRI combined with parametric imaging based on the Hilbert transform.

Authors:  Narjes Benameur; Enrico Gianluca Caiani; Younes Arous; Nejmeddine Ben Abdallah; Tarek Kraiem
Journal:  MAGMA       Date:  2017-02-20       Impact factor: 2.310

7.  Parametric subharmonic imaging using a commercial intravascular ultrasound scanner: an in vivo feasibility study.

Authors:  John R Eisenbrey; Anush Sridharan; Ebo D deMuinck; Marvin M Doyley; Flemming Forsberg
Journal:  J Ultrasound Med       Date:  2012-03       Impact factor: 2.153

8.  Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner.

Authors:  J R Eisenbrey; J K Dave; V G Halldorsdottir; D A Merton; P Machado; J B Liu; C Miller; J M Gonzalez; S Park; S Dianis; C L Chalek; K E Thomenius; D B Brown; V Navarro; F Forsberg
Journal:  Ultrasonics       Date:  2011-05-10       Impact factor: 2.890

9.  Three-dimensional subharmonic ultrasound imaging in vitro and in vivo.

Authors:  John R Eisenbrey; Anush Sridharan; Priscilla Machado; Hongjia Zhao; Valgerdur G Halldorsdottir; Jaydev K Dave; Ji-Bin Liu; Suhyun Park; Scott Dianis; Kirk Wallace; Kai E Thomenius; Flemming Forsberg
Journal:  Acad Radiol       Date:  2012-03-29       Impact factor: 3.173

10.  Perfusion estimation using contrast-enhanced 3-dimensional subharmonic ultrasound imaging: an in vivo study.

Authors:  Anush Sridharan; John R Eisenbrey; Ji-Bin Liu; Priscilla Machado; Valgerdur G Halldorsdottir; Jaydev K Dave; Hongjia Zhao; Yu He; Suhyun Park; Scott Dianis; Kirk Wallace; Kai E Thomenius; Flemming Forsberg
Journal:  Invest Radiol       Date:  2013-09       Impact factor: 6.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.